Targeted Treatment for IDH2-Mutated AML
EP. 1: Case Review: IDH2-Mutated Acute Myeloid Leukemia
Watch
EP. 2: Molecular Testing for Newly Diagnosed AML
EP. 3: Treatment of Patients With Chemo-Refractory AML
EP. 4: Enasidenib in Relapsed/Refractory Mutant IDH2 AML
EP. 5: Advantages of Oral Enasidenib in IDH2-Mutated AML
EP. 6: Toxicity Management in the Treatment of R/R AML
EP. 7: Targeted Therapies and the Treatment of AML
